Fichtl R - Search Results

1

Relaxor ferroelectricity and colossal magnetocapacitive coupling in ferromagnetic CdCr2S4.

Hemberger J, Lunkenheimer P, Fichtl R, Krug von Nidda HA, Tsurkan V, Loidl A. Hemberger J, et al. Among authors: fichtl r. Nature. 2005 Mar 17;434(7031):364-7. doi: 10.1038/nature03348. Nature. 2005. PMID: 15772656

2

Orbital freezing and orbital glass state in FeCr2S4.

Fichtl R, Tsurkan V, Lunkenheimer P, Hemberger J, Fritsch V, von Nidda HA, Scheidt EW, Loidl A. Fichtl R, et al. Phys Rev Lett. 2005 Jan 21;94(2):027601. doi: 10.1103/PhysRevLett.94.027601. Epub 2005 Jan 18. Phys Rev Lett. 2005. PMID: 15698228

3

Colossal magnetocapacitance and colossal magnetoresistance in HgCr2S4.

Weber S, Lunkenheimer P, Fichtl R, Hemberger J, Tsurkan V, Loidl A. Weber S, et al. Among authors: fichtl r. Phys Rev Lett. 2006 Apr 21;96(15):157202. doi: 10.1103/PhysRevLett.96.157202. Epub 2006 Apr 21. Phys Rev Lett. 2006. PMID: 16712192

4

Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients.

Holdsworth MT, Fichtl RE, Raisch DW, Hewryk A, Behta M, Mendez-Rico E, Wong CL, Cohen J, Bostwick S, Greenwald BM. Holdsworth MT, et al. Among authors: fichtl re. Pediatrics. 2007 Nov;120(5):1058-66. doi: 10.1542/peds.2006-3160. Pediatrics. 2007. PMID: 17974744

5

Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.

Stull DM, Bilmes R, Kim H, Fichtl R. Stull DM, et al. Among authors: fichtl r. Am J Health Syst Pharm. 2005 Jan 1;62(1):83-7. doi: 10.1093/ajhp/62.1.83. Am J Health Syst Pharm. 2005. PMID: 15658078 Clinical Trial. No abstract available.

6

Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis.

Murray HW, Lu CM, Brooks EB, Fichtl RE, DeVecchio JL, Heinzel FP. Murray HW, et al. Among authors: fichtl re. Infect Immun. 2003 Nov;71(11):6453-62. doi: 10.1128/IAI.71.11.6453-6462.2003. Infect Immun. 2003. PMID: 14573667 Free PMC article.

7

Incidence and impact of adverse drug events in pediatric inpatients.

Holdsworth MT, Fichtl RE, Behta M, Raisch DW, Mendez-Rico E, Adams A, Greifer M, Bostwick S, Greenwald BM. Holdsworth MT, et al. Among authors: fichtl re. Arch Pediatr Adolesc Med. 2003 Jan;157(1):60-5. doi: 10.1001/archpedi.157.1.60. Arch Pediatr Adolesc Med. 2003. PMID: 12517196

8

Surgical Infection Society position on vancomycin-resistant Enterococcus.

Davis JM, Huycke MM, Wells CL, Bohnen JM, Gadaleta D, Fichtl RE, Barie PS. Davis JM, et al. Among authors: fichtl re. Arch Surg. 1996 Oct;131(10):1061-8. doi: 10.1001/archsurg.1996.01430220055013. Arch Surg. 1996. PMID: 8857903

9

Models of relapse of experimental visceral leishmaniasis.

Murray HW, Hariprashad J, Fichtl RE. Murray HW, et al. Among authors: fichtl re. J Infect Dis. 1996 Apr;173(4):1041-3. doi: 10.1093/infdis/173.4.1041. J Infect Dis. 1996. PMID: 8603949

10

Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine.

Murray HW, Hariprashad J, Fichtl RE. Murray HW, et al. Among authors: fichtl re. Antimicrob Agents Chemother. 1993 Jul;37(7):1504-5. doi: 10.1128/AAC.37.7.1504. Antimicrob Agents Chemother. 1993. PMID: 8363382 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters